AI Article Synopsis
- Platelet-rich plasma and hyaluronic acid show promise as low-risk treatments for Achilles tendinopathy, but research findings are inconsistent and study quality is often questionable.
- Other treatments like bone marrow aspirate and stem cells have reported benefits, but there is a lack of strong evidence from high-level studies.
- The use of exosomes presents an exciting new area of research due to their potential to enhance tendon health, but future studies must standardize methods for better evaluation of these therapies.
Article Abstract
» Platelet-rich plasma and hyaluronic acid are low-risk and potentially high-reward treatments for Achilles tendinopathy, although clinical studies have yielded mixed results with questionable methodological quality» Case series and reports have reported that bone marrow aspirate, stem cells, and amniotic membrane products can improve functional outcomes, alleviate pain, and facilitate return to sport and activities, but high-level evidence studies are lacking» Exosomes are a promising novel biologic with laboratory studies showing improved collagen organization and cell proliferation, greater tendon mechanical properties, and prevention of extracellular matrix breakdown.» Standardization of protocols with clear reporting is necessary for future studies evaluating orthobiologic therapies for Achilles tendon injuries.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2106/JBJS.RVW.24.00144 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!